CELIA
OREJA GUEVARA
Profesora asociada de Ciencias de la Salud
Hospital Universitario de la Princesa
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (15)
2024
-
Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: Discover study
Multiple Sclerosis and Related Disorders, Vol. 90
-
Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023
Neurologia, Vol. 39, Núm. 2, pp. 196-208
-
Defining a standard set of health outcomes for patients with relapsing-remitting multiple sclerosis
Multiple Sclerosis and Related Disorders, Vol. 84
2023
-
XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (I)
Revista de neurologia, Vol. 77, Núm. 1, pp. 19-30
-
XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (II)
Revista de neurologia, Vol. 77, Núm. 2, pp. 47-60
2022
-
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology
Frontiers in immunology, Vol. 13, pp. 842354
2021
-
Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry
PLoS ONE, Vol. 16, Núm. 10 October
-
Risk and outcomes of COVID-19 in patients with multiple sclerosis
European Journal of Neurology, Vol. 28, Núm. 11, pp. 3712-3721
-
Systematic review of the safety and effectiveness of peripheral neurostimulation of the sphenopalatine ganglion for the treatment of refractory chronic cluster headache
Neurologia, Vol. 36, Núm. 6, pp. 440-450
2020
-
Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study
PLoS ONE, Vol. 15, Núm. 4
-
Three-Year Effectiveness of Dimethyl Fumarate in Multiple Sclerosis: A Prospective Multicenter Real-World Study
CNS Drugs, Vol. 34, Núm. 12, pp. 1275-1286
-
Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population
Journal of Neurology, Vol. 267, Núm. 8, pp. 2362-2371
2019
-
Cognitive dysfunctions and assessments in multiple sclerosis
Frontiers in Neurology, Vol. 10, Núm. JUN
2016
-
Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus
Neurology: Neuroimmunology and NeuroInflammation, Vol. 3, Núm. 3
2015
-
Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial
Neurology: Neuroimmunology and NeuroInflammation, Vol. 2, Núm. 5, pp. e147